Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Markwirth

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Herz|January 14, 2025
[Vaccination and cardiovascular diseases]Markus Therre, Mert Tokcan, Philipp Markwirth, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2026
Atrial and ventricular longitudinal strain in elite cyclistsTom Lagendijk, Philipp Markwirth, Ortwin Schäfer, et al.
Talanta|January 1, 2026
Capillary blood microsampling and LC-Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-BDiana Kretschmer, Mert Tokcan, Philipp Markwirth, et al.
European Journal of Heart Failure|March 2, 2026
Contemporary heart failure evidence in 2025: a joint summary of key trials from the European Journal of Heart Failure and ESC Heart Failure JournalJan Biegus, Antoni Bayes-Genis, Stephan von Haehling, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2026
Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic SyndromeMert Tokcan, Mathias Hohl, Carolin Victoria Schneider, et al.
Journal of the American Heart Association|July 21, 2025
Renal Denervation Improves Uremic Cardiomyopathy in Rats With Chronic Kidney DiseasePhilipp Markwirth, Simina-Ramona Selejan, Mathias Hohl, et al.
Circulation Research|February 8, 2022
Renal Denervation Prevents Atrial Arrhythmogenic Substrate Development in CKDMathias Hohl, Simina-Ramona Selejan, Jan Wintrich, et al.
European Journal of Heart Failure|April 9, 2026
European Journal of Heart Failure International Expert Position Paper Utilisation, Optimisation, and Clinical Benefits of Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure with a Reduced Ejection FractionMichael Böhm, Jabir Abdullakutty, Johann Bauersachs, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Herz|January 14, 2025
[Vaccination and cardiovascular diseases]Markus Therre, Mert Tokcan, Philipp Markwirth, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2026
Atrial and ventricular longitudinal strain in elite cyclistsTom Lagendijk, Philipp Markwirth, Ortwin Schäfer, et al.
Talanta|January 1, 2026
Capillary blood microsampling and LC-Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-BDiana Kretschmer, Mert Tokcan, Philipp Markwirth, et al.
European Journal of Heart Failure|March 2, 2026
Contemporary heart failure evidence in 2025: a joint summary of key trials from the European Journal of Heart Failure and ESC Heart Failure JournalJan Biegus, Antoni Bayes-Genis, Stephan von Haehling, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2026
Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic SyndromeMert Tokcan, Mathias Hohl, Carolin Victoria Schneider, et al.
Journal of the American Heart Association|July 21, 2025
Renal Denervation Improves Uremic Cardiomyopathy in Rats With Chronic Kidney DiseasePhilipp Markwirth, Simina-Ramona Selejan, Mathias Hohl, et al.
Circulation Research|February 8, 2022
Renal Denervation Prevents Atrial Arrhythmogenic Substrate Development in CKDMathias Hohl, Simina-Ramona Selejan, Jan Wintrich, et al.
European Journal of Heart Failure|April 9, 2026
European Journal of Heart Failure International Expert Position Paper Utilisation, Optimisation, and Clinical Benefits of Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure with a Reduced Ejection FractionMichael Böhm, Jabir Abdullakutty, Johann Bauersachs, et al.
Pageof 1